The relationship between mean arterial pressure and terlipressin in hepatorenal syndrome-acute kidney injury reversal: A post hoc analysis. [PDF]
Cullaro G +5 more
europepmc +1 more source
Protective effect of long-chain polyunsaturated fatty acids on hepatorenal syndrome in rats. [PDF]
Duailibe JBB +4 more
europepmc +1 more source
Comparison of hepatorenal syndrome incidence and outcomes using previous and current diagnostic criteria in cirrhotic patients. [PDF]
Akbas MM +3 more
europepmc +1 more source
Development and validation of a risk prediction model for hepatorenal syndrome in hepatic failure patients based on glucose-6-phosphate dehydrogenase and hepatic and renal function biochemical parameters. [PDF]
Liu H +5 more
europepmc +1 more source
Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis. [PDF]
Wan YM +5 more
europepmc +1 more source
Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome. [PDF]
Gonzalez-Garay AG +4 more
europepmc +1 more source
Hepatorenal syndrome (HRS) is a form of kidney function impairment that characteristically occurs in cirrhosis. Recent changes in terminology have led to acute HRS being referred to as acute kidney injury (AKI)-HRS and chronic HRS as chronic kidney disease (CKD)-HRS.
Père Gines, Elsa Sola, Paolo Angeli
exaly +8 more sources
The hepatorenal syndrome is defined as functional renal failure in advanced chronic or acute liver disease with portal hypertension. Morphologic abnormalities of the kidneys are frequently absent and tubular function is preserved. Patients with the hepatorenal syndrome are characterized by progressive splanchnic and systemic vasodilation and decreased ...
Ludwig, Kramer, Walter H, Hörl
core +5 more sources

